IPV
Sponsors
Pauline Verdijk, University of Chile, Aga Khan University, Centers for Disease Control and Prevention, University of Virginia
Conditions
ApneaApnea NeonatalGastroenteritisHealthyPertussis, Whooping cough
Pertussis, Whooping coughPolioPoliomyelitisPrematurity
Phase 1
Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults
CompletedNCT01708720
Start: 2011-08-31End: 2012-02-29Updated: 2014-02-21
Safety and Immunogenicity of a New Inactivated Poliovirus Vaccine in Infants
CompletedNCT01709071
Start: 2012-02-29End: 2013-05-31Updated: 2014-02-21
Immunogenicity and Safety of recombinant acellular pertusis-containing vaccine (TdaP) and a pedriatric recombinant acellular pertussis-containing vaccine (DTaP) in healthy children
Active, not recruitingTCTR20190201001
Start: 2019-07-01Target: 140Updated: 2026-03-30
Phase 3
Assessment of Community Transmission of Sabin Type 2 Virus in Bangladesh
NCT02477046
Start: 2015-04-30End: 2017-06-30Target: 810Updated: 2016-10-26
A Study to Evaluate Immunogenicity of Various Schedules of Inactivated Polio Vaccine
WithdrawnNCT03016949
Start: 2017-07-31End: 2018-11-30Updated: 2017-06-27
A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV
CompletedNCT03239496
Start: 2017-10-23End: 2018-11-13Updated: 2023-07-21
Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)
CompletedNCT04481191
Start: 2020-08-25End: 2021-05-08Updated: 2024-07-26
A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants
CompletedNCT06331156
Start: 2024-03-22End: 2024-10-22Updated: 2025-10-22
Phase 4
Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine
NCT01841671
Start: 2013-04-30End: 2014-06-30Target: 570Updated: 2014-05-20
Polio End-game Strategies - Poliovirus Type 2 Challenge Study
CompletedNCT02189811
Start: 2014-09-30End: 2016-05-31Updated: 2016-05-03
Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules
CompletedNCT02412514
Start: 2015-04-30End: 2015-12-31Updated: 2016-07-20
Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV
CompletedNCT03310073
Start: 2016-07-31End: 2017-03-31Updated: 2017-11-08
Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines
CompletedNCT03530124
Start: 2018-07-17End: 2021-11-01Updated: 2024-02-14
Assessment of Poliovirus Type 2 Immunogenicity of One and Two Dose Schedule With IPV and fIPV When Administered at 9-13 Months of Age in Bangladesh
NCT03890497
Start: 2018-09-27End: 2022-09-30Target: 300Updated: 2022-04-13
Immunogenicity of Intramuscular and Intradermal IPV
TerminatedNCT04063150
Start: 2019-10-06End: 2020-03-25Updated: 2022-05-18
Unknown Phase
Serological Survey on Monitoring the Positive Rate After Vaccination of Inactivated Polio Vaccine
CompletedNCT02643446
Start: 2015-08-31End: 2017-07-31Updated: 2017-08-01
Randomized Controlled Study on T-PEP Versus IPV Method for Lower Respiratory Airways Clearance in Tetraplegic Tracheotomized Spinal Cord Injured Patients
WithdrawnNCT04142814
Start: 2022-02-28End: 2023-08-31Updated: 2022-04-28